Acceleron Pharma Inc.
METHODS FOR DOSING AN ACTRIIB ANTAGONIST AND MONITORING OF TREATED PATIENTS

Last updated:

Abstract:

In certain aspects, the present invention provides methods for dosing a patient with an ActRIIb antagonist and methods for managing patients treated with an ActRIIb anatagonist. In certain aspects, the methods involve measuring one or more hematologic parameters in a patient.

Status:
Application
Type:

Utility

Filling date:

27 May 2021

Issue date:

21 Apr 2022